Why is Clinitech Lab falling/rising?

As of 26-Sep, Clinitech Laboratory Ltd's stock is currently priced at Rs 46.20, reflecting an increase of Rs 2.2 or 5.0%. Today's price summary indicates that the stock outperformed its sector by 6.26%, despite opening with a loss of 3.18%. The stock has shown high volatility today, with an intraday range of Rs 4.4 and a volatility of 5%. Additionally, the stock's delivery volume has increased significantly, rising by 66.67% against the 5-day average, suggesting a rise in investor participation. However, the stock's performance over the past month shows a decline of 7.60%, and it has underperformed the benchmark Sensex, which has only decreased by 0.45% during the same period.
Broader market context reveals that Clinitech's short-term performance contrasts sharply with the benchmark. While the stock has gained 3.13% over the past week, the Sensex has fallen by 2.66%, indicating a relative strength in the stock compared to the broader market. However, the year-to-date performance remains concerning, with a decline of 41.42% against the Sensex's modest gain of 2.93%. This suggests that while there may be short-term positive movements, the overall trend for Clinitech Laboratory Ltd remains negative in the longer term, reflecting broader challenges faced by the company.